Progress in the function and regulation of ADP-ribosylation

Science Signaling

Volumn 4, Issue 174, 2011, Pages

  Hottiger, Michael O ^a   Boothby, Mark ^b   Koch Nolte, Friedrich ^c   Lüscher, Bernhard ^d   Martin, Niall M B ^e   Plummer, Ruth ^f   Wang, Zhao Qi ^g,h   Ziegler, Mathias ⁱ  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d RWTH AACHEN UNIVERSITY   (Germany)

^e Babraham Research Campus Babraham   (United Kingdom)

^f NEWCASTLE UNIVERSITY   (United Kingdom)

^g FRITZ LIPMANN INSTITUTE   (Germany)

^h FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

ⁱ UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

8 FLUORO 3,4 DIHYDRO 2 [4 (METHYLAMINOMETHYL)PHENYL]PYRROLO[3,4,5 E,F][2]BENZAZEPIN 6(5H) ONE; ADENOSINE DIPHOSPHATE; ANTINEOPLASTIC AGENT; CARBOPLATIN; CEP 9722; GEMCITABINE; GLYCOSIDASE; GPI 21016; INIPARIB; INO 1001; LT 673; MK 4827; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; OLAPARIB; SIRTUIN; SIRTUIN 1; TEMOZOLOMIDE; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG; VELIPARIB; ENZYME INHIBITOR; NICOTINAMIDE ADENINE DINUCLEOTIDE;

ADENOSINE DIPHOSPHATE RIBOSYLATION; BREAST CANCER; CATALYSIS; CELL ENERGY; CELL STRUCTURE; CLINICAL TRIAL; CONFERENCE PAPER; DEVELOPMENTAL BIOLOGY; GLIOBLASTOMA; HUMAN; LUNG CANCER; LYMPHOMA; MELANOMA; NONHUMAN; OVARY TUMOR; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PROCESSING; SOLID TUMOR; SWITZERLAND; ANIMAL; ARTICLE; DRUG ANTAGONISM; ENERGY METABOLISM; METABOLISM; ORGANIZATION;

ADENOSINE DIPHOSPHATE; ANIMALS; CONGRESSES AS TOPIC; ENERGY METABOLISM; ENZYME INHIBITORS; HUMANS; NAD; POLY(ADP-RIBOSE) POLYMERASES; SIRTUINS; SWITZERLAND;

EID: 79957511957     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2001645     Document Type: Conference Paper

References (21)

1. K. Aktories, J. T. Barbieri, Bacterial cytotoxins: Targeting eukaryotic switches. Nat. Rev. Microbiol. 3, 397-410 (2005).
2. F. Berger, M. H. Ramírez-Hernández, M. Ziegler, The new life of a centenarian: Signalling functions of NAD(P). Trends Biochem. Sci. 29, 111-118 (2004).
3. M. O. Hottiger, P. O. Hassa, B. Lüscher, H. Schüler, F. Koch-Nolte, Toward a unified nomenclature for mammalian ADP-ribosyltransferases. Trends Biochem. Sci. 35, 208-219 (2010).
4. P. O. Hassa, S. S. Haenni, M. Elser, M. O. Hottiger, Nuclear ADP-ribosylation reactions in mammalian cells: Where are we today and where are we going? Microbiol. Mol. Biol. Rev. 70, 789-829 (2006).
5. G. Magni, G. Orsomando, N. Raffelli, S. Ruggieri, Enzymology of mammalian NAD metabolism in health and disease. Front. Biosci. 13, 6135-6154 (2008).
6. P. Chambon, J. D. Weill, P. Mandel, Nicotinamide mononucleotide activation of new DNA-dependent polyadenylic acid synthesizing nuclear enzyme. Biochem. Biophys. Res. Commun. 11, 39-43 (1963).
7. H. M. Alkhatib, D. F. Chen, B. Cherney, K. Bhatia, V. Notario, C. Giri, G. Stein, E. Slattery, R. G. Roeder, M. E. Smulson, Cloning and expression of cDNA for human poly(ADP-ribose) polymerase. Proc. Natl. Acad. Sci. U.S.A. 84, 1224-1228 (1987).
8. K. Uchida, T. Morita, T. Sato, T. Ogura, R. Yamashita, S. Noguchi, H. Suzuki, H. Nyunoya, M. Miwa, T. Sugimura, Nucleotide sequence of a full-length cDNA for human fibroblast poly(ADP-ribose) polymerase. Biochem. Biophys. Res. Commun. 148, 617-622 (1987).
9. R. Schneider, B. Auer, C. Kühne, H. Herzog, H. Klocker, H. J. Burtscher, M. Hirsch-Kauffmann, U. Wintersberger, M. Schweiger, Isolation of a cDNA clone for human NAD+: Protein ADP-ribosyltransferase. Eur. J. Cell Biol. 44, 302-307 (1987).
10. P. O. Hassa, M. O. Hottiger, The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases. Front. Biosci. 13, 3046-3082 (2008).
11. H. Kleine, B. Lüscher, Learning how to read ADPribosylation. Cell 139, 17-19 (2009).
12. L. Davidovic, M. Vodenicharov, E. B. Affar, G. G. Poirier, Importance of poly(ADP-ribose) glycohydrolase in the control of poly(ADP-ribose) metabolism. Exp. Cell Res. 268, 7-13 (2001).
13. M. Miwa, T. Sugimura, Splitting of the riboseribose linkage of poly(adenosine diphosphaterobose) by a calf thymus extract. J. Biol. Chem. 246, 6362-6364 (1971).
14. W. Min, Z.-Q. Wang, Poly (ADP-ribose) glycohydrolase (PARG) and its therapeutic potential. Front. Biosci. 14, 1619-1626 (2009).
15. F. Koch-Nolte, S. Kernstock, C. Mueller-Dieckmann, M. S. Weiss, F. Haag, Mammalian ADPribosyltransferases and ADP-ribosylhydrolases. Front. Biosci. 13, 6716-6729 (2008).
16. C. Mueller-Dieckmann, S. Kernstock, M. Lisurek, J. P. von Kries, F. Haag, M. S. Weiss, F. Koch-Nolte, The structure of human ADP-ribosylhydrolase 3 (ARH3) provides insights into the reversibility of protein ADP-ribosylation. Proc. Natl. Acad. Sci. U.S.A. 103, 15026-15031 (2006).
17. H. Kleine, E. Poreba, K. Lesniewicz, P. O. Hassa, M. O. Hottiger, D. W. Litchfield, B. H. Shilton, B. Lüscher, Substrate-assisted catalysis by PARP10 limits its activity to mono-ADP-ribosylation. Mol. Cell 32, 57-69 (2008).
18. M. Rouleau, A. Patel, M. J. Hendzel, S. H. Kaufmann, G. G. Poirier, PARP inhibition: PARP1 and beyond. Nat. Rev. Cancer 10, 293-301 (2010).
19. C. Underhill, M. Toulmonde, H. Bonnefoi, A review of PARP inhibitors: From bench to bedside. Ann. Oncol. 22, 268-279 (2010)
20. G. Donmez, D. Wang, D. E. Cohen, L. Guarente, SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10. Cell 142, 320-332 (2010).
21. Funding: F. K.-N. receives an honorarium from Analytical Services GmbH for sales of antibodies and recombinant proteins developed in the laboratory. R.P. is named as an inventor on the patent for AG014699, a PARP inhibitor in development. N.M.B.M. is formerly of KuDOS Pharmaceuticals, where the PARP inhibitor olaparib was identified and initially developed.